Explorer les evidences

Among female undergraduates in a tertiary institution in south eastern Nigeria who had been screened for cervical cancer, all were screened at a cost of ₦1,001–₦2,000.

Nigeriacancer du col de l'utéruspublié 2021Journal of preventive medicine and hygienePubMeddocument de 11 observations

83 593 womenOver 83,593 women were screened for cervical cancer in Nigeria.

Nigeriacancer du col de l'utérusAfrica CDCdocument de 52 observations

71,4 %Using a cut-off value of 0.45, the positive predictive value of squamous cell carcinoma antigen was 71.4%.

Nigeriacancer du col de l'utéruspublié 2025European journal of medical researchPubMeddocument de 8 observations

67,5 %67.5% of the respondents had heard of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2024Reproductive healthPubMeddocument de 16 observations

Nigeria has low cervical cancer screening and vaccination rates.

Nigeriacancer du col de l'utéruspublié 2024BMC infectious diseasesPubMeddocument de 10 observations

3,3 score_on_5_point_Likert_scaleThe median attitude score toward cervical cancer among rural women in North Central Nigeria was 3.3 on a five-point Likert scale.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

53,5 %Over half (53.5%) of the respondents had heard of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2020The Pan African medical journalPubMeddocument de 5 observations

57,7 %Out of 23,409 women living with HIV who visited the sites during March to August 2023, 13,518 (57.7%) were eligible for cervical cancer screening.

Nigeriacancer du col de l'utérusobservé March to August 2023publié 2026BMC health services researchPubMeddocument de 5 observations

732 women732 (7.1%) of the screened women had a positive screening test suggestive of precancerous lesions or cervical cancer.

Nigeriacancer du col de l'utérusobservé October 2020 to July 2021publié 2023Reproductive healthPubMeddocument de 9 observations

0,929 odds_ratioTreatment delay was an independent predictor of lower brachytherapy utilization (p = 0.037, OR = 0.929, 95% CI = 0.868–0.996).

Nigeriacancer du col de l'utérusobservé March 2021 to June 2024PubMeddocument de 6 observations

19 %19% of the 231 women had basic information on the cause of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2021Cancer treatment and research communicationsPubMeddocument de 11 observations

59,2 %59.2% of rural women in North Central Nigeria had fair/good general knowledge of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

4 rankCervical cancer is the fourth most diagnosed cancer among women globally.

Nigeriacancer du col de l'utéruspublié 2023BMC women's healthPubMeddocument de 5 observations

46,9 %246 (46.9%) of the 514 surveyed women had good knowledge of cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2023African journal of reproductive healthPubMeddocument de 4 observations

27,3 %Awareness of cervical cancer screening methods was reported by 27.3% of respondents in a community health outreach program in Ituku, Enugu State, Nigeria.

Nigeriacancer du col de l'utérusobservé 2024publié 2026Rural and remote healthPubMeddocument de 8 observations

26,6 %26.6% of rural women in North Central Nigeria cited hospitals as a source of information on cervical cancer.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

12,2 %Only 12.2% of rural women in North Central Nigeria reported ever undergoing cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

97,2 %420 (97.2%) of the respondents said they had not been screened for cervical cancer.

Nigeriacancer du col de l'utéruspublié 2023Cancer treatment and research communicationsPubMeddocument de 5 observations

315 women315 (43.0%) of VIA-positive women received treatment using thermal ablation.

Nigeriacancer du col de l'utérusobservé October 2020 to July 2021publié 2023Reproductive healthPubMeddocument de 9 observations

84,3 %Uptake of pap smear increased to 84.3% in the intervention group post-intervention.

Nigeriacancer du col de l'utéruspublié 2022BMC women's healthPubMeddocument de 5 observations

42,3 %42.3% of rural women in North Central Nigeria recognized HPV infection as a risk factor for cervical cancer.

Nigeriacancer du col de l'utérus · infection à HPVpublié 2026Rural and remote healthPubMeddocument de 21 observations

65,5 %The South West region had the highest cervical cancer screening rate at 65.5%, while the North West region had the lowest at 22.4%.

Nigeriacancer du col de l'utérusobservé March to August 2023publié 2026BMC health services researchPubMeddocument de 5 observations

60,3 %The health education intervention yielded a 60.3% net gain in uptake of cervical cancer screening post intervention.

Nigeriacancer du col de l'utéruspublié 2023African journal of reproductive healthPubMeddocument de 4 observations

290 cases290 out of 507 mothers living with HIV had knowledge of cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2026BMC public healthPubMeddocument de 8 observations

67 371 womenAmong the 83,593 women screened, 67,371 (81%) received visual inspection with acetic acid (VIA) as their primary screening method.

Nigeriacancer du col de l'utérusobservé 2021publié 2023BMC public healthPubMeddocument de 12 observations